| Previous Close | 2.7700 |
| Open | 2.7800 |
| Bid | 2.7700 x 0 |
| Ask | 2.9000 x 0 |
| Day's Range | 2.7800 - 2.8500 |
| 52 Week Range | 1.7800 - 11.2000 |
| Volume | 2,943 |
| Avg. Volume | 14,643 |
| Market Cap | 63.185M |
| Beta (5Y Monthly) | 3.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.4000 |
| Earnings Date | Aug. 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.48 |
- Newsfile
Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 8, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating in the 22nd Annual H.C. Wainwright Global Investment Conference on September 14-16, 2020. Fred Colen, Neovasc's President and CEO, will present ...
- Newsfile
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the "Meeting").At the Meeting, the shareholders of the Company (the "Shareholders") re-elected board members Steven Rubin, Paul Geyer, Doug Janzen, Norman Radow, Alexei Marko and Fred Colen ...
- Newsfile
Neovasc Announces Partial Prepayment of Convertible Debenture
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 17, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that Strul Medical Group LLC ("SMG") exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the "May Warrants") issued pursuant to a Securities Purchase Agreement dated May 26, 2020 at an exercise price of US$2.634 per May Warrant for aggregate exercise proceeds to the Company of US$1,319,634.00 (the "Exercise ...
